Exaggerated vasomotor response to ANG II in rats with fetal programming of hypertension associated with exposure to a low-protein diet during gestation

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 291, Issue 4, 2006, Pages

  Yzydorczyk, C ^a   Gobeil Jr , F ^b   Cambonie, G ^a,d   Lahaie, I ^a   Le N L O ^a   Samarani, S ^a   Ahmad, A ^a   Lavoie, J C ^a   Oligny, L L ^a   Pladys, P ^a,c   Hardy, P ^a   Nuyt, Anne Monique ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c SERVICE DE RHUMATOLOGIE   (France)

^d HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Angiotensin; Isolated vessels; Oxidative stress

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; APOCYNIN; DIPHENYLIODONIUM SALT; ENDOTHELIN; POTASSIUM CHLORIDE; SUPEROXIDE DISMUTASE; THROMBOXANE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAROTID ARTERY; ENDOTHELIUM CELL; HYPERTENSION; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN RESTRICTION; VASOMOTOR REFLEX;

EID: 33749343487     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00798.2005     Document Type: Article

References (50)

1. Barker DJ. Fetal programming of coronary heart disease. Trends Endocrinol Metab 13: 364-368, 2002.
2. Barker DJ and Martyn CN. The maternal and fetal origins of cardiovascular disease. J Epidemiol Community Health 46: 8-11, 1992.
3. Barker DJ, Osmond C, Golding J, Kuh D, and Wadsworth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 298: 564-567, 1989.
4. Berry C, Hamilton CA, Brosnan MJ, Magill FG, Berg GA, McMurray JJ, and Dominiczak AF. Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation 101: 2206-2212, 2000.
5. Boulanger CM, Caputo L, and Levy BI. Endothelial AT1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension 26: 752-757, 1995.
6. Brawley L, Itoh S, Torrens C, Barker A, Bertram C, Poston L, and Hanson M. Dietary protein restriction in pregnancy induces hypertension and vascular defects in rat male offspring. Pediatr Res 54: 83-90, 2003.
7. Cai H and Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844, 2000.
8. Dzau VJ. Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 37: 1047-1052, 2001.
9. Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, and Diz DI. Counterregulatory actions of angiotensin-(1-7). Hypertension 30: 535-541, 1997.
10. Franco MC, Akamine EH, Di Marco GS, Casarini DE, Fortes ZB, Tostes RC, Carvalho MH, and Nigro D. NADPH oxidase and enhanced superoxide generation in intrauterine undernourished rats: involvement of the renin-angiotensin system. Cardiovasc Res 59: 767-775, 2003.
11. Frias MA, Dubouloz F, Rebsamen MC, and Lang U. Prostacyclin production in rat aortic smooth muscle cells: role of protein kinase C, phospholipase D and cyclooxygenase-2 expression. Cardiovasc Res 60: 438-446, 2003.
12. Griendling KK, Minieri CA, Ollerenshaw JD, and Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 1141-1148, 1994.
13. Gunther S, Gimbrone MA Jr, and Alexander RW. Regulation by angiotensin II of its receptors in resistance blood vessels. Nature 287: 230-232, 1980.
14. Heitzer T, Wenzel U, Hink U, Krollner D, Skatchkov M, Stahl RA, MacHarzina R, Brasen JH, Meinertz T, and Munzel T. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int 55: 252-260, 1999.
15. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, and Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 346: 1954-1962, 2002.
16. Lamireau D, Nuyt AM, Hou X, Bernier S, Beauchamp M, Gobeil F Jr, Lahaie I, Varma DR, and Chemtob S. Altered vascular function in fetal programming of hypertension. Stroke 33: 2992-2998, 2002.
17. Langley-Evans S and Jackson A. Intrauterine programming of hypertension: nutrient-hormone interactions. Nutr Rev 54: 163-169, 1996.
18. Langley-Evans SC. Fetal programming of cardiovascular function through exposure to maternal undernutrition. Proc Nutr Soc 60: 505-513, 2001.
19. Langley-Evans SC, Gardner DS, and Jackson AA. Association of disproportionate growth of fetal rats in late gestation with raised systolic blood pressure in later life. J Reprod Fertil 106: 307-312, 1996.
20. Langley-Evans SC and Jackson AA. Captopril normalises systolic blood pressure in rats with hypertension induced by fetal exposure to maternal low protein diets. Comp Biochem Physiol A 110: 223-228, 1995.
21. Langley-Evans SC, Welham SJ, Sherman RC, and Jackson AA. Weanling rats exposed to maternal low-protein diets during discrete periods of gestation exhibit differing severity of hypertension. Clin Sci (Lond) 91: 607-615, 1996.
22. Lassegue B, Alexander RW, Nickenig G, Clark M, Murphy TJ, and Griendling KK. Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. Mol Pharmacol 48: 601-609, 1995.
23. Law CM and Shiell AW. Is blood pressure inversely related to birth weight? The strength of evidence from a systematic review of the literature. J Hypertens 14: 935-941, 1996.
24. Li Y, Zhu H, Kuppusamy P, Roubaud V, Zweier JL, and Trush MA. Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems. J Biol Chem 273: 2015-2023, 1998.
25. McMillen IC and Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 85: 571-633, 2005.
26. McMullen S, Gardner DS, and Langley-Evans SC. Prenatal programming of angiotensin II type 2 receptor expression in the rat. Br J Nutr 91: 133-140, 2004.
27. Miller FJ Jr, Gutterman DD, Rios CD, Heistad DD, and Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 82: 1298-1305, 1998.
28. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K, and Munzel T. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90: E58-E65, 2002.
29. Mulvany MJ. Small artery remodeling and significance in the development of hypertension. News Physiol Sci 17: 105-109, 2002.
30. Nakajima M, Hutchinson HG, Fujinaga M, Hayashida W, Morishita R, Zhang L, Horiuchi M, Pratt RE, and Dzau VJ. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA 92: 10663-10667, 1995.
31. Nishiyama A, Fukui T, Fujisawa Y, Rahman M, Tian RX, Kimura S, and Abe Y. Systemic and regional hemodynamic responses to tempol in angiotensin II-infused hypertensive rats. Hypertension 37: 77-83, 2001.
32. Nozawa Y, Matsuura N, Miyake H, Yamada S, and Kimura R. Effects of TH-142177 on angiotensin II-induced proliferation, migration and intracellular signaling in vascular smooth muscle cells and on neointimal thickening after balloon injury. Life Sci 64: 2061-2070, 1999.
33. Pladys P, Lahaie I, Cambonie G, Thibault G, Le NL, Abran D, and Nuyt AM. Role of brain and peripheral angiotensin II in hypertension and altered arterial baroreflex programmed during fetal life in rat. Pediatr Res 55: 1042-1049, 2004.
34. Pladys P, Sennlaub F, Brault S, Checchin D, Lahaie I, Le NL, Bibeau K, Cambonie G, Abran D, Brochu M, Thibault G, Hardy P, Chemtob S, and Nuyt AM. Microvascular rarefaction and decreased angiogenesis in rats with fetal programming of hypertension associated with exposure to a low-protein diet in utero. Am J Physiol Regul Integr Comp Physiol 289: R1580-R1588, 2005.
35. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, and Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923, 1996.
36. Rajagopalan S, Laursen JB, Borthayre A, Kurz S, Keiser J, Haleen S, Giaid A, and Harrison DG. Role for endothelin-1 in angiotensin II-mediated hypertension. Hypertension 30: 29-34, 1997.
37. Sahajpal V and Ashton N. Increased glomerular angiotensin II binding in rats exposed to a maternal low protein diet in utero. J Physiol 563: 193-201, 2005.
38. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de B, I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, and Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 100: 8258-8263, 2003.
39. Saruta T. Mechanism of glucocorticoid-induced hypertension. Hypertens Res 19: 1-8, 1996.
40. Schiffrin EL. Vascular endothelin in hypertension. Vascul Pharmacol 43: 19-29, 2005.
41. Sherman RC and Langley-Evans SC. Early administration of angiotensin-converting enzyme inhibitor captopril, prevents the development of hypertension programmed by intrauterine exposure to a maternal low-protein diet in the rat. Clin Sci (Lond) 94: 373-381, 1998.
42. Sherman RC and Langley-Evans SC. Antihypertensive treatment in early postnatal life modulates prenatal dietary influences upon blood pressure in the rat. Clin Sci (Lond) 98: 269-275, 2000.
43. Tangalakis K, Lumbers ER, Moritz KM, Towstoless MK, and Wintour EM. Effect of cortisol on blood pressure and vascular reactivity in the ovine fetus. Exp Physiol 77: 709-717, 1992.
44. Touyz RM. Reactive oxygen species and angiotensin II signaling in vascular cells - implications in cardiovascular disease. Braz J Med Biol Res 37: 1263-1273, 2004.
45. Touyz RM and Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52: 639-672, 2000.
46. Vehaskari VM, Stewart T, Lafont D, Soyez C, Seth D, and Manning J. Kidney angiotensin and angiotensin receptor expression in prenatally programmed hypertension. Am J Physiol Renal Physiol 287: F262-F267, 2004.
47. Woodall SM, Johnston BM, Breier BH, and Gluckman PD. Chronic maternal undernutrition in the rat leads to delayed postnatal growth and elevated blood pressure of offspring. Pediatr Res 40: 438-443, 1996.
48. Woods LL, Ingelfinger JR, Nyengaard JR, and Rasch R. Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res 49: 460-467, 2001.
49. Wyse DG. On the "Normalization" of active developed force of isolated helical strips of muscular and elastic arteries for variation in wall thickness. J Pharmacol Methods 4: 313-326, 1980.
50. Zalba G, San Jose G, Moreno MU, Fortuno MA, Fortuno A, Beaumont FJ, and Diez J. Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 38: 1395-1399, 2001.